Helen Thackray aims to demonstrate the effectiveness of Netherton syndrome treatment by focusing on skin penetration, target binding, and functional cure potential. Charlie Gayer expects continued ORLADEYO revenue growth despite Q4 slowdown from patient approval challenges and holiday timing.